The 16 Career Development Award and Postdoctoral Fellowship research grants include projects exploring numerous disease subtypes treatments, including rare disease states like T-cell lymphomas, as well as novel therapeutics.
On May 30, 2024, the U.S. Food and Drug Administration (FDA) announced it has approved lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) for adults with relapsed or refractory mantle cell lymphoma (MCL) who have received two or more prior lines of…
The new visual identity for the Lymphoma Research Foundation symbolizes unity, vitality, and inclusivity within the lymphoma community. The rebranding also includes enhancements to the Foundation's digital platforms and resources, ensuring that patients, caregivers, physicians, researchers, and donors can easily access the information and support they need.
Lymphoma Research Foundation Funds 28 New Grants Supporting the Next Generation of Lymphoma Scientists New York, NY (May 20, 2024) – The Lymphoma Research Foundation (LRF), the nation’s largest nonprofit organization devoted to funding innovative lymphoma research and serving the…
On May 15, 2024, the U.S. Food and Drug Administration (FDA) announced it has approved lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) for adults with relapsed or refractory follicular lymphoma (FL) who have received two or more prior lines of systemic…
On March 7, 2024, the U.S. Food and Drug Administration (FDA) announced it has approved Bruton tyrosine kinase inhibitor (BTKi), zanubrutinib (Brukinsa, BeiGene USA, Inc.) with obinutuzumab for the treatment of adult patients with relapsed/refractory follicular lymphoma (FL) after two…
Celebrating the Original ‘Chemo Diva’ Upon receiving a lymphoma diagnosis, it’s not uncommon to search for others like you who are going through a similar experience. That sense of community and support, of seeing your own story reflected to you,…
Where Are They Now? Ryan Lynch, MD Dr. Ryan Lynch is a hematologist-oncologist at Fred Hutchinson Cancer Center. When did you become interested in the study of medicine? In lymphoma specifically? I had a great opportunity while I was in…
Advancing Cures and Developing the Next Generation of Lymphoma Researchers Growing up in Spoleto, Italy, Laura Pasqualucci, MD, loved classical music. While her appreciation for music led her to attend a conservatory to study the art form, it was ultimately…
Morton Coleman, MD Innovation Fund Dr. Morton Coleman is a world-renowned and highly respected medical oncologist with nearly 60 years of experience in the field, specializing in the treatment of patients with lymphoma, multiple myeloma, and leukemia. In 2023, the…
